journal article·2015-02-24

Delivery of RNA Nanoparticles into Colorectal Cancer Metastases Following Systemic Administration

Piotr Rychahou, Farzin Haque, Yi Shu, Yekaterina Zaytseva, Heidi L. Weiss, Eun Y. Lee, William Mustain, Joseph Valentino, Peixuan Guo, B. Mark Evers

ACS Nano· Volume 9· Issue 2
Publisher page

Abstract

The majority of deaths from all cancers, including colorectal cancer (CRC), is a result of tumor metastasis to distant organs. To date, an effective and safe system capable of exclusively targeting metastatic cancers that have spread to distant organs or lymph nodes does not exist. Here, we constructed multifunctional RNA nanoparticles, derived from the three-way junction (3WJ) of bacteriophage phi29 motor pRNA, to target metastatic cancer cells in a clinically relevant mouse model of CRC metastasis. The RNA nanoparticles demonstrated metastatic tumor homing without accumulation in normal organ tissues surrounding metastatic tumors. The RNA nanoparticles simultaneously targeted CRC cancer cells in major sites of metastasis, such as liver, lymph nodes, and lung. Our results demonstrate the therapeutic potential of these RNA nanoparticles as a delivery system for the treatment of CRC metastasis.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Bacteriophages and microbial interactions · Cancer Research and Treatments · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Markey Cancer Center, ‡Department of Surgery, §Pathology and Laboratory Medicine, ∥Nanobiotechnology Center, and ⊥Department of Pharmaceutical Sciences, The University of Kentucky, Lexington, Kentucky 40536, United States

Funding

National Cancer Institute · National Institute of Biomedical Imaging and Bioengineering · National Institutes of Health

References (52)

Show source-provided references
1. Siegel R. · Ca-Cancer J. Clin. · 2014 · 64 · 10410.3322/caac.21220 ↗
2. Siegel R. · Ca-Cancer J. Clin. · 2014 · 64 · 910.3322/caac.21208 ↗
3. Wanebo H. J. · Am. J. Surg. · 1978 · 135 · 8110.1016/0002-9610(78)90014-4 ↗
4. Yoon S. S. · Oncologist · 1999 · 4 · 19710.1634/theoncologist.4-3-197 ↗
5. Akinc A. · Nat. Biotechnol. · 2008 · 26 · 56110.1038/nbt1402 ↗
6. Fu S. · Mol. Cancer Ther. · 2011 · 10 · 130010.1158/1535-7163.MCT-11-0259 ↗
7. Schroeder A. · Nat. Rev. Cancer · 2012 · 12 · 3910.1038/nrc3180 ↗
8. Sudimack J. · Adv. Drug Delivery Rev. · 2000 · 41 · 14710.1016/S0169-409X(99)00062-9 ↗
9. Lu Y. · Adv. Drug Delivery Rev. · 2002 · 54 · 67510.1016/S0169-409X(02)00042-X ↗
10. Haque F. · Nano Today · 2012 · 7 · 24510.1016/j.nantod.2012.06.010 ↗
11. Guo P. X. · Science · 1987 · 236 · 69010.1126/science.3107124 ↗
12. Guo P. · Mol. Cell · 1998 · 2 · 14910.1016/S1097-2765(00)80124-0 ↗
13. Guo P. · Nat. Nanotechnol. · 2010 · 5 · 83310.1038/nnano.2010.231 ↗
14. Abdelmawla S. · Mol. Ther. · 2011 · 19 · 131210.1038/mt.2011.35 ↗
15. Shu Y. · RNA · 2013 · 19 · 76710.1261/rna.037002.112 ↗
16. Shu D. · Nat. Nanotechnol. · 2011 · 6 · 65810.1038/nnano.2011.105 ↗
17. Afonin K. A. · Methods · 2014 · 67 · 25610.1016/j.ymeth.2013.10.013 ↗
18. Kasprzak W. · Methods · 2011 · 54 · 23910.1016/j.ymeth.2010.12.010 ↗
19. Shopsowitz K. E. · Small · 2014 · 10 · 162310.1002/smll.201302676 ↗
20. Lee J. B. · Nat. Mater. · 2012 · 11 · 31610.1038/nmat3253 ↗
21. Grabow W. W. · Acc. Chem. Res. · 2014 · 47 · 187110.1021/ar500076k ↗
22. Zhang H. · RNA · 2013 · 19 · 122610.1261/rna.037077.112 ↗
23. Khisamutdinov E. F. · Nucleic Acids Res. · 2014 · 42 · 999610.1093/nar/gku516 ↗
24. Jasinski D. L. · ACS Nano · 2014 · 8 · 762010.1021/nn502160s ↗
25. Shu D. · Nucleic Acids Res. · 2014 · 42 · e1010.1093/nar/gkt885 ↗
26. Elliott V. A. · PLoS One · 2014 · 9 · e9743210.1371/journal.pone.0097432 ↗
27. Wang C. · Biomaterials · 2014 · 35 · 121510.1016/j.biomaterials.2013.08.091 ↗
28. Murphy E. A. · Proc. Natl. Acad. Sci. U. S. A. · 2008 · 105 · 934310.1073/pnas.0803728105 ↗
29. Werner M. E. · Biomaterials · 2011 · 32 · 854810.1016/j.biomaterials.2011.07.067 ↗
30. Na J. H. · Biomaterials · 2011 · 32 · 525210.1016/j.biomaterials.2011.03.076 ↗
31. Peiris P. M. · ACS Nano · 2012 · 6 · 878310.1021/nn303833p ↗
32. Kusumoto K. · ACS Nano · 2013 · 7 · 753410.1021/nn401317t ↗
33. Luo G. · Int. J. Pharm. · 2010 · 385 · 15010.1016/j.ijpharm.2009.10.014 ↗
34. Li S. D. · J. Controlled Release · 2008 · 126 · 7710.1016/j.jconrel.2007.11.002 ↗
35. Yang F. · Biomaterials · 2013 · 34 · 568910.1016/j.biomaterials.2013.03.047 ↗
36. Ji S. · Cancer Biol. Ther. · 2012 · 13 · 20610.4161/cbt.13.4.18692 ↗
37. Wang Y. · Mol. Ther. · 2013 · 21 · 191910.1038/mt.2013.135 ↗
38. Lim S. H. · Cancer Gene Ther. · 2011 · 18 · 81710.1038/cgt.2011.52 ↗
39. Murphy E. A. · Mol. Cancer Ther. · 2011 · 10 · 97210.1158/1535-7163.MCT-10-0729 ↗
40. Chen Y. · Mol. Ther. · 2010 · 18 · 165010.1038/mt.2010.136 ↗
41. Guo S. · Hum. Gene Ther. · 2005 · 16 · 109710.1089/hum.2005.16.1097 ↗
42. Shu D. · J. Nanosci. Nanotechnol. · 2003 · 3 · 29510.1166/jnn.2003.160 ↗
43. Shu Y. · Methods · 2011 · 54 · 20410.1016/j.ymeth.2011.01.008 ↗
44. Khaled A. · Nano Lett. · 2005 · 5 · 179710.1021/nl051264s ↗
45. Matsumura Y. · Cancer Res. · 1986 · 46 · 6387
46. McNamara J. O. · Nat. Biotechnol. · 2006 · 24 · 100510.1038/nbt1223 ↗
47. Morikawa K. · Cancer Res. · 1988 · 48 · 6863
48. Gulhati P. · Cancer Res. · 2011 · 71 · 324610.1158/0008-5472.CAN-10-4058 ↗
49. Rychahou P. G. · Ann. Surg. · 2006 · 243 · 83310.1097/01.sla.0000220040.66012.a9 ↗
50. Allred D. C. · Mod. Pathol. · 1998 · 11 · 155
51. Bruns C. J. · Neoplasia · 1999 · 1 · 5010.1038/sj.neo.7900005 ↗
52. Shu Y. · Nat. Protoc. · 2013 · 8 · 163510.1038/nprot.2013.097 ↗